Industry news

On January 18, the "Action Plan for Improving Drug Standards" seminar sponsored by the China Medical News and Information Association was successfully held in Beijing. The aim of the workshop is to strengthen the understanding and implementation of drug standards in the pharmaceutical industry and improve the quality and safety of drugs.

China Medical News and Information Association President Zhang Jixiang, Vice president and Secretary General Ye Jianhua, Vice President Wei Pengyan attended the meeting. Zhang Wei, President of China Drug Regulatory Research Society, Liang Zhiyuan, Director General of the Drug Registration Department of the State Drug Administration, Song Zonghua, Deputy Director of the Business Management Department of the China National Pharmacopoeia Committee, and Liang Chenggang, Director of the Rope Room of the China Food and Drug Control Institute attended the meeting and gave a keynote report.

In his speech, Zhang Wei introduced the history of Chinese pharmacopoeia and the construction of drug standard system in detail. He pointed out that the pharmacopoeia is a collection of all drug standards, which fully reflects the core orientation of the national will in the field of drugs. He reviewed the development of Chinese pharmacopoeia, from ancient medical and pharmaceutical texts to the evolution of modern pharmacopoeia, emphasizing the important role of pharmacopoeia in ensuring the quality and safety of drugs. At the same time, he also shared the situation of other countries' pharmacopoeia in the world, which provided reference for the compilation of our country's pharmacopoeia.

Liang Zhiyuan in the report in-depth interpretation of the "Drug standard management Measures" introduction process and its core content. He stressed that the method is a major innovation in China's drug supervision work and has far-reaching significance in promoting the high-quality development of the drug industry. He explained the definition of drug registration standards and differentiated in detail the differences between drug registration standards and national drug standards. He also stressed the important role of implementing the main responsibility of drug holders in continuously improving and improving drug registration standards.

Song Zonghua introduced the preparation and management of pharmacopoeia, emphasizing the indispensable role of pharmacopoeia in regulating the drug market and ensuring the safety of public drugs. At the same time, she also shared the progress of the preparation of the 2025 version of Chinese pharmacopoeia.

Liang Chenggang introduced in detail the process of formulating the national standard for human insulin and the overall idea. He explained the content of the human insulin standard in a simple way, and highlighted the situation of the standard and international standards.

Shen Jingwang, the moderator of the meeting and vice president of China Pharmaceutical News and Information Association, stressed the important role of drug standards in protecting public health and promoting the development of the pharmaceutical industry in his summary. He said that the "Measures for the Management of Drug Standards" will be formally implemented from January 2024, and the timely holding of this meeting will help strengthen the understanding and implementation of drug standards by all parties, and improve the quality and safety of drugs.